ICICI Prudential Nifty Pharma Index Fund is a below-average performer in its category with a BullWiser Honest Score of 5.9/10 — above the Other Scheme - Index Funds category median of 4.7/10 across 679 funds. Its 3-year CAGR of 24.2% outperforms the Other Scheme - Index Funds category average of 6.6% by +17.7 percentage points. Note: ICICI Prudential Nifty Pharma Index Fund is a Regular plan, which includes distributor commissions in its expense ratio. The Direct plan variant of this fund offers a lower TER and higher net returns for cost-conscious investors.
Fund Details
Fund Name
ICICI Prudential Nifty Pharma Index Fund
Category
Plan Type
Direct · Growth
Expense Ratio
--
Verdict
🟠 Below Avg
1Y Return
14.3%
3Y CAGR
24.2%
vs Category Average — Other Scheme - Index Funds
3Y CAGR
This fund+17.7% vs category avg
Expense Ratio (lower is better)
TER data not available
Honest Score
This fund+1.2 vs category avg
Category: Other Scheme - Index Funds · 679 Direct-plan funds compared · 1% are High Quality
Frequently Asked Questions
What is the BullWiser Honest Score of ICICI Prudential Nifty Pharma Index Fund?
ICICI Prudential Nifty Pharma Index Fund has a BullWiser Honest Score of 5.9/10 (BELOW AVERAGE).
The score rates the fund across four pillars: returns quality, expense ratio, risk-adjusted performance (Sharpe ratio & max drawdown), and overall fund quality (AUM, age, consistency).
What is the expense ratio of ICICI Prudential Nifty Pharma Index Fund?
The Total Expense Ratio (TER) of ICICI Prudential Nifty Pharma Index Fund Direct Plan is --.
Choosing the Direct plan saves you the distributor commission baked into Regular plans — typically 0.5–1% per year — which compounds significantly over time.
What are the returns of ICICI Prudential Nifty Pharma Index Fund?
ICICI Prudential Nifty Pharma Index Fund has delivered 14.3% 1-year returns and
24.2% 3-year CAGR. For a full NAV history and comparison with category peers,
use BullWiser's MF Analyser.
Past performance is not a guarantee of future returns.
Is ICICI Prudential Nifty Pharma Index Fund a good investment?
BullWiser rates ICICI Prudential Nifty Pharma Index Fund as BELOW AVERAGE (Honest Score 5.9/10).
Always match a fund to your own risk profile and investment horizon.
Use the MF Analyser to compare it with peers in the Other Scheme - Index Funds category.
How does Direct Plan differ from Regular Plan for ICICI Prudential Nifty Pharma Index Fund?
The Regular plan of ICICI Prudential Nifty Pharma Index Fund includes a distributor commission of 0.5–1.5% per year built into the expense ratio. Switching to the Direct plan of the same fund eliminates this cost — same fund manager, same portfolio, but a lower TER that compounds significantly over time. Use BullWiser's MF Analyser to calculate your exact savings.
See Full Analysis on BullWiser
NAV chart, holdings, Direct vs Regular savings, Sharpe ratio, and personalised comparison — all free.
Open in MF Analyser →Browse Other Scheme - Index Funds Funds
⚠️ Disclaimer: BullWiser is an independent analysis platform, not a SEBI-registered investment advisor.
Honest Scores and verdicts are algorithmic assessments based on publicly available data.
They are not buy/sell recommendations. Please consult a financial advisor before investing.
Mutual fund investments are subject to market risks. Read all scheme-related documents carefully.